---
category: news
title: "Transgene, NEC and BostonGene Announce Strategic Collaboration for Two Ongoing Clinical Trials for Patients with Ovarian and Head & Neck Cancers"
excerpt: "Oct 6, 2020-- Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, NEC Corporation (NEC; TSE: 6701), a leader in IT and network technologies and BostonGene Corporation (BostonGene),"
publishedDateTime: 2020-10-06T05:30:00Z
originalUrl: "https://apnews.com/press-release/business-wire/science-business-technology-public-health-genomics-8c25dc2d68374a7c92201e1dc9434ae6"
webUrl: "https://apnews.com/press-release/business-wire/science-business-technology-public-health-genomics-8c25dc2d68374a7c92201e1dc9434ae6"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "zKOePX/aF8BepbG0wP9aqnXSZUn7ma+ryOgEsZg+TFQOgGL4Grtrycox5cAjiKrEM4YXw1qTMldzbOwGq+GMrE39fzwtO9bx2dxpLnEUpOpUz9WvOZjAnEfo/CcueC2avmLK5Sg+fnzXCSK4VZjD/uTaBZ6CSiLAKIvLLGCe42VDaPNKnI4kIAhfUWJP7J/uphE2JLNWJMayQCb/awdBa6Ev6PRKzK+tBB7MdG+N0NMAfKaZ7+9tNEUoDWX5BOyMBoYzx9WA3gIF2YGmCbcFdGC52FCiH5KG8ugmRR4iWKpsdzuAefzjasQzslvvJoGd91NBm+y2j5/gpn/yaOqfjlGd0PfsnUGPsWj9mT4rfok=;1t8pwnuwQgV2FL4chtZscQ=="
---

